| Features: |
| Treatment of disease with radiation, especially by selective irradiation with x-rays or other ionizing radiation and by ingestion of radioisotopes. Radiosensitizer Atorvaqone, (mitochondria inhibitor) decrease O2 consumption making more O2 available as a radiosensitizer. -Hypoxia (low oxygen levels) within tumors is a major cause of resistance to radiotherapy |
| Source: |
| Type: |
| For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream. In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects. |
| 5078- | SSE, | Rad, | Results from a Phase 1 Study of Sodium Selenite in Combination with Palliative Radiation Therapy in Patients with Metastatic Cancer |
| - | Trial, | Pca, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:201 Target#:1109 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid